SOCS3 and head and neck cancer: Overall the results indicate a significant reduction in SOCS3 expression in head and neck cancer in comparison to non-neoplastic tissues, and this decrease was observed at early stages (Figure 6-B), and even though we could not assess the subcellular localization of SOCS3 by immunohistochemistry some cases retained detectable expression levels.